Ati selectat numarul: Nr.1/2017
Filtreaza arhiva dupa:
AMISULPRIDE – INDUCED HYPERPROLACTINEMIA- CASE REPORT
BACKGROUND: Unul dintre cele mai discutate efecte adverse ale antipsihoticelor este hiperprolactinemia. Antagoniiştii dopaminergici blochează receptorii D2 ai celulelor lactotrofe și previn inhibiţia secreţiei de prolactină ceea ce determină...
C REACTIVE PROTEIN, A POSSIBLE BIOMARKER FOR THE MAJOR DEPRESSIVE EPISODE
The central nervous system has a bidirectional communication with the immune system by many mechanisms that could link depression with an increase of the inflammation markers like C reactive...
THE IMPACT OF TREATMENT AND DURATION OF PSYCHOSIS ON RESIDUAL SYMPTOMS
Introduction: Literature data suggest that a longer duration of untreated psychosis or discontinuities in antipsychotic treatment impair...
COGNITIVE IMPAIRMENT IN MAJOR DEPRESSIVE DISORDER
Cognitive impairment was considered for a long time to be part of depression and it was expected to disappear as other mood symptoms improved with treatment. Because of this...
IMPLICATIONS OF THE INFLAMMATORY PROCESSES IN MAJOR DEPRESSIVE EPISODE
Abstract There are an increasing number of evidences that suggests that the immune system and inflammatory processes can contribute to MDD pathogenesis in a significant proportion. In this article,...
ETHICAL IMPLICATIONS OF PLACEBO USING IN CLINICAL PRACTICE
Mulți autori consideră că istoria efectului placebo se suprapune practic peste istoria medicinei. Efectul placebo este extrem de des folosit în activitatea clinică, între 41- 99% dintre clinicieni la nivel...
